美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Lakewood-Amedex Biotherapeutics (Direct Listing)

0.3100

-0.1795-36.67%

盤後：0.2558-0.0542-17.49%19:59 EDT

成交量：4,006.95萬

成交額：2,536.70萬

市值：73.46萬

市盈率：-0.10

高：0.3610

開：0.3463

低：0.2830

收：0.4895

52周最高：98.20

52周最低：0.2830

股本：236.97萬

流通股本：84.77萬

量比：160.32

換手率：4726.85%

股息：- -

股息率：- -

每股收益(TTM):-3.1006

每股收益(LYR):-8.3987

淨資產收益率：-402.84%

總資產收益率：-139.40%

市淨率：0.17

市盈率(LYR):-0.04

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Lakewood-Amedex Biotherapeutics公布Bisphosphocin®化合物在尿路與肺部感染適應症中的積極臨床前數據

Lakewood-Amedex Biotherapeutics公布針對感染性糖尿病足潰瘍近期臨床分離株的積極數據

Lakewood-Amedex Biotherapeutics宣佈Nu-3治療感染性糖尿病足潰瘍的2a期臨床試驗完成首例患者給藥

Lakewood-Amedex Biotherapeutics提交招股説明書，特定售股股東擬轉售至多451.24萬股普通股

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www-web.itiger.com/hant/stock/LABT"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABT\",,,,,undefined,":{"symbol":"LABT","market":"US","secType":"STK","nameCN":"Lakewood-Amedex Biotherapeutics (Direct Listing)","latestPrice":0.31,"timestamp":1792785600000,"preClose":0.4895,"halted":0,"volume":40069483,"hourTrading":{"tag":"盘后","latestPrice":0.255776,"preClose":0.31,"latestTime":"19:59 EDT","volume":1736284,"amount":531676.560495,"timestamp":1792799973597,"change":-0.054224,"changeRate":-0.174916,"amplitude":0.379032},"delay":0,"changeRate":-0.36670071501532175,"floatShares":847700,"shares":2369700,"eps":-3.1005669,"marketStatus":"休市中","change":-0.1795,"latestTime":"10-23 16:00:00 EDT","open":0.3463,"high":0.361,"low":0.283,"amount":25366971.9224318,"amplitude":0.159346,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.1005669,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1793001600000},"marketStatusCode":7,"adr":0,"listingDate":1776916800000,"exchange":"NASDAQ","adjPreClose":0.4895,"preHourTrading":{"tag":"盘前","latestPrice":0.3422,"preClose":0.4895,"latestTime":"09:29 EDT","volume":14983803,"amount":10141397.931186091,"timestamp":1792762193454,"change":-0.1473,"changeRate":-0.300919,"amplitude":1.628601},"postHourTrading":{"tag":"盘后","latestPrice":0.255776,"preClose":0.31,"latestTime":"19:59 EDT","volume":1736284,"amount":531676.560495,"timestamp":1792799973597,"change":-0.054224,"changeRate":-0.174916,"amplitude":0.379032},"volumeRatio":160.31769070392937},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABT\",,,,,undefined,":{"symbol":"LABT","floatShares":847700,"roa":"-139.40%","roe":"-402.84%","lyrEps":-8.39872,"volumeRatio":160.31769070392937,"shares":2369700,"dividePrice":0,"high":0.361,"amplitude":0.159346,"preClose":0.4895,"low":0.283,"week52Low":0.283,"pbRate":"0.17","week52High":98.2,"institutionHeld":0,"latestPrice":0.31,"eps":-3.1005669,"divideRate":0,"volume":40069483,"delay":0,"ttmEps":-3.1005669,"open":0.3463,"prevYearClose":80,"prevWeekClose":0.58,"prevMonthClose":0.9553,"prevQuarterClose":0.9553,"fiveDayClose":0.58,"twentyDayClose":1.67,"sixtyDayClose":1.93},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-06-22","symbol":"LABT","defaultRemindTime":1782135000000,"type":"split","dateTimestamp":1782100800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LABT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LABT","date":"2026-10-14","current":-0.099982,"percent":1,"low":-12.282138,"twenty":-2.610215,"median":-0.805893,"eighty":-0.644091,"high":-0.223798,"avg":-2.012785,"sd":2.902502,"marketCap":1644326},"quantilePoints":[{"date":"2026-05-08","current":-12.282138,"twenty":-12.192813,"median":-11.891342,"eighty":-11.604759,"marketCap":47257207},{"date":"2026-05-15","current":-7.294845,"twenty":-12.043939,"median":-11.649421,"eighty":-11.314454,"marketCap":28067917},{"date":"2026-05-22","current":-2.865088,"twenty":-11.850402,"median":-11.258627,"eighty":-3.412052,"marketCap":11023817},{"date":"2026-05-29","current":-2.716586,"twenty":-11.716415,"median":-6.438817,"eighty":-2.758568,"marketCap":10452435},{"date":"2026-06-05","current":-2.512255,"twenty":-11.604759,"median":-3.225364,"eighty":-2.559299,"marketCap":9666247},{"date":"2026-06-12","current":-2.69016,"twenty":-11.537766,"median":-2.813168,"eighty":-2.512255,"marketCap":10350760},{"date":"2026-06-18","current":-2.241304,"twenty":-11.42611,"median":-2.776507,"eighty":-2.512255,"marketCap":8623724},{"date":"2026-06-26","current":-1.276597,"twenty":-10.242559,"median":-2.72924,"eighty":-2.388094,"marketCap":4911883},{"date":"2026-07-02","current":-1.116845,"twenty":-7.294845,"median":-2.69016,"eighty":-1.477578,"marketCap":4725718},{"date":"2026-07-10","current":-0.893476,"twenty":-5.58279,"median":-2.580737,"eighty":-1.276597,"marketCap":3780575},{"date":"2026-07-17","current":-0.62611,"twenty":-3.536511,"median":-2.512255,"eighty":-1.062695,"marketCap":2649266},{"date":"2026-07-24","current":-1.03562,"twenty":-3.225364,"median":-2.41344,"eighty":-0.92732,"marketCap":4382030},{"date":"2026-07-31","current":-0.653185,"twenty":-2.937143,"median":-2.34533,"eighty":-0.879262,"marketCap":2763829},{"date":"2026-08-07","current":-0.754716,"twenty":-2.857942,"median":-1.477578,"eighty":-0.80819,"marketCap":3193440},{"date":"2026-08-14","current":-0.78856,"twenty":-2.830251,"median":-1.371504,"eighty":-0.793975,"marketCap":3336643},{"date":"2026-08-21","current":-0.706322,"twenty":-2.806803,"median":-1.276597,"eighty":-0.779084,"marketCap":5189616},{"date":"2026-08-28","current":-0.803079,"twenty":-2.760875,"median":-1.18284,"eighty":-0.754039,"marketCap":5900523},{"date":"2026-09-04","current":-0.612791,"twenty":-2.735567,"median":-1.116845,"eighty":-0.749426,"marketCap":4502407},{"date":"2026-09-11","current":-0.661169,"twenty":-2.730282,"median":-1.03562,"eighty":-0.735555,"marketCap":4857860},{"date":"2026-09-18","current":-0.59989,"twenty":-2.721648,"median":-0.925628,"eighty":-0.713886,"marketCap":4407619},{"date":"2026-09-25","current":-0.588602,"twenty":-2.70073,"median":-0.89016,"eighty":-0.694712,"marketCap":4324680},{"date":"2026-10-02","current":-0.299977,"twenty":-2.666042,"median":-0.854556,"eighty":-0.672485,"marketCap":2204046},{"date":"2026-10-09","current":-0.255437,"twenty":-2.637905,"median":-0.808867,"eighty":-0.657975,"marketCap":1876792},{"date":"2026-10-14","current":-0.223798,"twenty":-2.610215,"median":-0.805893,"eighty":-0.644091,"marketCap":1644326}],"updateTime":1792927828500},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABT\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1198083838","title":"Lakewood-Amedex Biotherapeutics公布Bisphosphocin®化合物在尿路與肺部感染適應症中的積極臨床前數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1198083838","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198083838?lang=zh_tw&edition=fundamental","pubTime":"2026-10-07 20:03","pubTimestamp":1791374637,"startTime":"0","endTime":"0","summary":"Lakewood-Amedex Biotherapeutics公布Bisphosphocin®化合物在尿路与肺部感染适应症中的积极临床前数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LABT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197010422","title":"Lakewood-Amedex Biotherapeutics公布針對感染性糖尿病足潰瘍近期臨床分離株的積極數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1197010422","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197010422?lang=zh_tw&edition=fundamental","pubTime":"2026-09-28 20:07","pubTimestamp":1790597256,"startTime":"0","endTime":"0","summary":"Lakewood-Amedex Biotherapeutics公布针对感染性糖尿病足溃疡近期临床分离株的积极数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105630662","title":"Lakewood-Amedex Biotherapeutics宣佈Nu-3治療感染性糖尿病足潰瘍的2a期臨床試驗完成首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=1105630662","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105630662?lang=zh_tw&edition=fundamental","pubTime":"2026-09-24 20:03","pubTimestamp":1790251387,"startTime":"0","endTime":"0","summary":"Lakewood-Amedex Biotherapeutics宣布，其候选药物Nu-3用于治疗感染性糖尿病足溃疡的2a期临床试验已完成首例患者给药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LABT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176530600","title":"Lakewood-Amedex Biotherapeutics提交招股説明書，特定售股股東擬轉售至多451.24萬股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1176530600","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176530600?lang=zh_tw&edition=fundamental","pubTime":"2026-09-19 05:33","pubTimestamp":1789767200,"startTime":"0","endTime":"0","summary":"Lakewood-Amedex Biotherapeutics向美国证券交易委员会（SEC）提交了招股说明书文件，该文件涉及特定售股股东对至多4,512,400股普通股的转售安排。\n根据这份SEC备案文件，公司将针对上述数量的普通股进行转售登记。这一举措旨在为符合条件的售股股东提供股份流通的通道，但公司本身并未通过此次转售获得任何资金收益。\n本次转售计划的核心在于，相关售股股东将依照市场条件和监管框架，在适当时机灵活执行股份出售操作，以优化其投资组合结构或实现资产配置目标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LABT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LABT\",params:#limit:6,delay:false,,,undefined,":[]}}